PMV Pharmaceuticals, Inc. (PMVP) key performance indicators and operating metrics (2 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Overall Response Rate (Response Evaluation Criteria in Solid Tumors Version 1.1, Recommended Phase 2 Dose) | 34.00 percent | FY2025-Q3 |
| Overall Response Rate (Ovarian Cancer Cohort) | 46.00 percent | FY2025-Q3 |
Back to PMVP overview · PMVP earnings · PMVP holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.